While the Oncology Care Model (OCM) is likely not a sustainable mode for oncology care, it will probably inform what payment structure comes next, said Michael Kolodziej, MD, vice president, chief innovation officer, ADVI Health, Inc.
We are writing on behalf of the Part B Access for Seniors and Physicians (ASP) Coalition, which is committed to advancing life-saving innovation in the U.S. We are greatly concerned about a proposal by the Centers for Medicare & Medicaid Services (CMS) to implement an unprecedented, mandatory experiment affecting Medicare beneficiaries who take Part B-covered
A proposed 2019 rule change for services furnished under the Medicare Physician Fee Schedule (MPFS) is not going down well with oncologists. In July, the Centers for Medicare & Medicaid Services (CMS) issued the proposed change that would lower some payments for patient evaluation and maintenance (E/M) services.
Medicare cuts and budgetary adjustments are driving a Del Rio cancer treatment clinic into a possible closure. The facility, Rio Bravo Cancer and Blood, 1301 Ave. G, Del Rio, Texas, is the only one of its kind in this part of the state, and serves approximately 1,000 patients. Rio Bravo Cancer and Blood Practice Administrator,
Patient advocacy groups have objected swiftly to a proposal that would grant Medicare Part D health plans new liberty to reject or restrict certain protected-class drugs, which the plans have been required for more than a decade to cover.
Today, 35% of oncology drugs in the pipeline are oral, according to a recent report by the Community Oncology Alliance (COA). With the rise of oral oncolytic prescribing and development, more oncology practices are implementing in-office dispensing programs to provide a seamless treatment experience for patients.
Radiation oncologists are concerned about the possibility of mandatory participation in a radiation oncology demonstration after HHS Secretary Alex Azar indicated such a model was on the way. Ted Okon, executive director of the Community Oncology Alliance, said layering mandatory demonstrations on top of the voluntary Oncology Care Model doesn’t make much sense. The American
With a two-year delay on implementation of a new coding and payment structure for Medicare patients’ office visits, physician groups say they hope to work with the Centers for Medicare & Medicaid Services (CMS) to ensure doctors are fairly paid.
Utilization management strategies allow payers to manage the cost of healthcare benefits, but according to Ray D. Page, DO, PhD, FACOI, President, the Center for Cancer and Blood Disorders, Weatherford, TX, this practice often leads to burdensome requirements on oncologists and an increased administrative workload.
On August 7, 2018, the Centers for Medicare & Medicaid Services (CMS) directed Medicare Advantage plans to use step therapy for Part B drugs. Read the full article on Journal of Clinical Pathways here.